Stay updated on IMGN632 in BPDCN Clinical Trial
Sign up to get notified when there's something new on the IMGN632 in BPDCN Clinical Trial page.

Latest updates to the IMGN632 in BPDCN Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the usual study content, indicating the record is blocked from public access. This access restriction replaces the study details with an error page, reflecting a site-level access issue rather than a data update.SummaryDifference19%

- Check29 days agoChange DetectedResults Posted entry added with detailed efficacy and safety outcomes for BPDCN and related diseases. Locations section updated to 29 sites, including new entries such as University of Alabama at Birmingham.SummaryDifference5%

- Check36 days agoChange DetectedThe page revision label was updated to v3.6.6, signaling a small update to the page rather than changes to study data.SummaryDifference0.0%

- Check57 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5. This is a platform/backend update and does not change the study content presented.SummaryDifference0.0%

- Check71 days agoChange DetectedThe page’s revision label was updated to a newer build (v3.6.4), indicating an internal update; the visible study details appear unchanged.SummaryDifference0.0%

- Check93 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This represents a small update to the page's version and metadata without changing visible study details.SummaryDifference0.0%

Stay in the know with updates to IMGN632 in BPDCN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IMGN632 in BPDCN Clinical Trial page.